“[Sec. 1] (a) The effective date of the following provisions of the Federal Food, Drug, and Cosmetic Act is hereby postponed until January 1, 1940: Sections
402(c) [342(c) of this title]; 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k) of this title]; 501(a), (4) [351(a)(4) of this title]; 502(b), (d), (e), (f), (g), and (h) [352(b), (d) to (h) of this title]; 601(e) [361(e) of this title]; and 602(b) [362(b) of this title].

“(b) The Secretary of Agriculture shall promulgate regulations further postponing to July 1, 1940[,] the effective date of the provisions of sections
403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k)]; 502(b), (d), (e), (f), (g), and (h) [352(b), (d) to (h) of this title]; and 602(b) [362(b) of this title] of such Act with respect to lithographed labeling which was manufactured prior to February 1, 1939, and to containers bearing labeling which, prior to February 1, 1939, was lithographed, etched, stamped, pressed, printed, fused or blown on or in such containers, where compliance with such provisions would be unduly burdensome by reason of causing the loss of valuable stocks of such labeling or containers, and where such postponement would not prevent the public interest being adequately served: Provided, That in no case shall such regulations apply to labeling which would not have complied with the requirements of the Food and Drugs Act of June 30, 1906, as amended.

“Sec. 2. (a) The provisions of section
8 [section
10 of this title], paragraph fifth, under the heading ‘In the case of food:’, of the Food and Drugs Act of June 30, 1906, as amended, and regulations promulgated thereunder, and all other provisions of such Act to the extent that they may relate to the enforcement of such section
8 [section
10 of this title] and of such regulations, shall remain in force until January 1, 1940.

“(b) The provisions of such Act of June 30, 1906, as amended, [sections
1 to
5,
7 to
15, and
372a of this title] to the extent that they impose, or authorize the imposition of, any requirement imposed by section 403(k) of the Federal Food, Drug, and Cosmetic Act [section
343(k) of this title], shall remain in force until January 1, 1940.

“(c) Notwithstanding the provisions of section 1 of this Act, such section shall not apply—

“(1) to the provisions of section 502(d) and (e) of the Federal Food, Drug, and Cosmetic Act [352(d), (e) of this title], insofar as such provisions relate to any substance named in section
8 [section
10 of this title], paragraph second, under the heading ‘In the case of drugs:’, of the Food and Drugs Act of June 30, 1906, as amended, or a derivative of any such substance; or

“(2) to the provisions of section 502(b), (d), (e), (f), (g), and (h) of the Federal Food, Drug, and Cosmetic Act [352(b), (d) to (h) of this title], insofar as such provisions relate to drugs to which section
505 [355 of this title] of such Act applies.”

Effective Date

Act June 25, 1938, ch. 675, § 1002(a), formerly § 902(a),52 Stat. 1059; renumbered § 1002(a),Pub. L. 111–31, div. A, title I, § 101(b)(2),June 22, 2009, 123 Stat. 1784, provided that: “This Act [enacting this chapter and repealing sections
1 to
5 and
7 to
15 of this title], shall take effect twelve months after the date of its enactment [June 25, 1938]. The Federal Food and Drugs Act of June 30, 1906, as amended (U.S.C., 1934 ed., title
21, secs.
1–15), shall remain in force until such effective date, and, except as otherwise provided in this subsection, is hereby repealed effective upon such date: Provided, That the provisions of section
701 [section
371 of this title] shall become effective on the enactment of this Act, and thereafter the Secretary is authorized hereby to (1) conduct hearings and to promulgate regulations which shall become effective on or after the effective date of this Act as the Secretary shall direct, and (2) designate prior to the effective date of this Act food having common or usual names and exempt such food from the requirements of clause (2) of section
403(i) [section
343(i) of this title] for a reasonable time to permit the formulation, promulgation, and effective application of definitions and standards of identity therefor as provided by section
401 [section
341 of this title]: Provided further, That sections
502(j),
505, and
601(a) [sections
352(j),
355,
361(a), respectively of this title], and all other provisions of this Act to the extent that they may relate to the enforcement of such sections, shall take effect on the date of the enactment of this Act, except that in the case of a cosmetic to which the proviso of section
601(a) [section
361(a) of this title], relates, such cosmetic shall not, prior to the ninetieth day after such date of enactment, be deemed adulterated by reason of the failure of its label to bear the legend prescribed in such proviso: Provided further, That the Act of March 4, 1923 (U.S.C., 1934 ed., title
21, sec.
6 [section
321a of this title]; 42 Stat. 1500, ch. 268), defining butter and providing a standard therefor; the Act of July 24, 1919 (U.S.C., 1934 ed., title
21, sec.
10 [section
321b of this title]; 41 Stat. 271, ch. 26], defining wrapped meats as in package form; and the amendment to the Food and Drugs Act, section
10A, approved August 27, 1935 (U.S.C. 1934 ed., Sup. III, title
21, sec.
14a [section
372a of this title]) shall remain in force and effect and be applicable to the provisions of this Act.”

Pub. L. 113–195, § 1,Nov. 26, 2014, 128 Stat. 2035, provided that: “This Act [enacting part I of subchapter V of this chapter and provisions set out as a note under section
360fff of this title] may be cited as the ‘Sunscreen Innovation Act’.”

Short Title of 2013 Amendment

Pub. L. 113–54, § 1,Nov. 27, 2013, 127 Stat. 587, provided that: “This Act [enacting part H of subchapter V and subpart 9 of part C of subchapter VII of this chapter and sections
353a–1 and
353b of this title, amending sections
331,
333,
352 to
353a,
353b,
353c, and
360eee–1 of this title, and enacting provisions set out as notes under this section and sections
331,
333, and
353 of this title] may be cited as the ‘Drug Quality and Security Act’.”

Pub. L. 113–54, title I, § 101,Nov. 27, 2013, 127 Stat. 587, provided that: “This Act [probably means “This title”, enacting subpart 9 of part C of subchapter VII of this chapter and sections
353a–1 and
353b of this title, amending sections
331,
352,
353a,
353b, and
353c of this title, and enacting provisions set out as notes under this section and section
331 of this title] may be cited as the ‘Compounding Quality Act’.”

Pub. L. 113–54, title II, § 201,Nov. 27, 2013, 127 Stat. 599, provided that: “This title [enacting part H of subchapter V of this chapter, amending sections
331,
333,
352,
353, and
360eee–1 of this title, and enacting provisions set out as notes under sections
331,
333, and
353 of this title] may be cited as the ‘Drug Supply Chain Security Act’.”

Pub. L. 113–14, title I, § 101(a),June 13, 2013, 127 Stat. 451, provided that: “This title [amending sections
379j–11 to
379j–13 of this title, enacting provisions set out as notes under sections
379j–11 to
379j–13 of this title, and repealing provisions set out as notes under section
379j–11 of this title] may be cited as the ‘Animal Drug User Fee Amendments of 2013’.”

Pub. L. 113–14, title II, § 201(a),June 13, 2013, 127 Stat. 464, provided that: “This title [amending sections
379j–21 and
379j–22 of this title, enacting provisions set out as notes under sections
379j–21 and
379j–22 of this title, and repealing provisions set out as notes under sections
379j–21 and
379j–22 of this title] may be cited as the ‘Animal Generic Drug User Fee Amendments of 2013’.”

Short Title of 2012 Amendment

Pub. L. 112–193, § 1,Oct. 5, 2012, 126 Stat. 1443, provided that: “This Act [amending sections
352,
379j, and
379j–42 of this title and enacting provisions set out as a note under section
379j–42 of this title] may be cited as the ‘FDA User Fee Corrections Act of 2012’.”

Pub. L. 112–144, title I, § 101(a),July 9, 2012, 126 Stat. 996, provided that: “This title [amending sections
379g,
379h, and
379h–2 of this title, enacting provisions set out as notes under sections
379g and
379h–2 of this title, and repealing provisions set out as notes under sections
379g and
379h–2 of this title] may be cited as the ‘Prescription Drug User Fee Amendments of 2012’.”

Pub. L. 112–144, title II, § 201(a),July 9, 2012, 126 Stat. 1002, provided that: “This title [enacting section
379d–3 of this title, amending sections
360e,
379i,
379j, and
379j–1 of this title, enacting provisions set out as notes under section
379i of this title, and repealing provisions set out as notes under section
379i of this title] may be cited as the ‘Medical Device User Fee Amendments of 2012’.”

Pub. L. 112–144, title III, § 301(a),July 9, 2012, 126 Stat. 1008, provided that: “This title [enacting sections
379d–4 and
379j–41 to
379j–43 of this title, amending sections
352 and
379d–3 of this title, and enacting provisions set out as notes under sections
379j–41 and
379j–43 of this title] may be cited as the ‘Generic Drug User Fee Amendments of 2012’.”

Pub. L. 112–144, title IV, § 401(a),July 9, 2012, 126 Stat. 1026, provided that: “This title [enacting sections
379j–51 to
379j–53 of this title, amending sections
379d–4 and
379g of this title, and enacting provisions set out as notes under sections
379g,
379j–51, and
379j–53 of this title] may be cited as the ‘Biosimilar User Fee Act of 2012’.”

Pub. L. 110–316, title I, § 101(a),Aug. 14, 2008, 122 Stat. 3509, provided that: “This title [enacting section
379j–13 of this title, amending sections
360b,
379j–11, and
379j–12 of this title, and enacting provisions set out as notes under sections
360b and
379j–11 of this title] may be cited as the ‘Animal Drug User Fee Amendments of 2008’.”

Pub. L. 110–316, title II, § 201(a),Aug. 14, 2008, 122 Stat. 3515, provided that: “This title [enacting sections
379j–21 and
379j–22 of this title, amending sections
379k,
379l, and
379o of this title, and enacting provisions set out as notes under sections
379j–21 and
379j–22 of this title] may be cited as the ‘Animal Generic Drug User Fee Act of 2008’.”

Pub. L. 110–85, title I, § 101(a),Sept. 27, 2007, 121 Stat. 825, provided that: “This title [enacting sections
379h–1 and
379h–2 of this title, amending sections
379g,
379h, and
379j–11 of this title, and enacting provisions set out as notes under sections
379g,
379h, and
379h–2 of this title] may be cited as the ‘Prescription Drug User Fee Amendments of 2007’.”

Pub. L. 110–85, title II, § 201(a),Sept. 27, 2007, 121 Stat. 842, provided that: “This title [enacting section
379j–1 of this title, amending sections
333,
360,
360i,
360m,
374,
379i, and
379j of this title, and enacting provisions set out as notes under section
379i of this title] may be cited as the ‘Medical Device User Fee Amendments of 2007’.”

Pub. L. 110–85, title III, § 301,Sept. 27, 2007, 121 Stat. 859, provided that: “This title [enacting section
360e–1 of this title, amending sections
360j,
360l, and
393a of this title and section
282 of Title
42, The Public Health and Welfare, enacting provisions set out as notes under section
360j of this title and section
282 of Title
42, and amending provisions set out as a note under section
284m of Title
42] may be cited as the ‘Pediatric Medical Device Safety and Improvement Act of 2007’.”

Pub. L. 110–85, title IV, § 401,Sept. 27, 2007, 121 Stat. 866, provided that: “This title [enacting section
355d of this title, amending section
355c of this title, and enacting provisions set out as a note under section
355c of this title] may be cited as the ‘Pediatric Research Equity Act of 2007’.”

Pub. L. 110–85, title V, § 501,Sept. 27, 2007, 121 Stat. 876, provided that: “This title [amending section
355a of this title and sections
284m,
285g–10,
288–6, and
290b of Title
42, The Public Health and Welfare, enacting provisions set out as a note under section
355a of this title, and amending provisions set out as a note under section
284m of Title
42] may be cited as the ‘Best Pharmaceuticals for Children Act of 2007’.”

Short Title of 2006 Amendment

Pub. L. 109–462, § 1,Dec. 22, 2006, 120 Stat. 3469, provided that: “This Act [enacting sections
379aa and
379aa–1 of this title, amending sections
331,
343,
352, and
381 of this title, and enacting provisions set out as notes under sections
331,
343,
352,
379aa, and
381 of this title] may be cited as the ‘Dietary Supplement and Nonprescription Drug Consumer Protection Act’.”

Short Title of 2005 Amendments

Pub. L. 109–59, title VII, § 7201,Aug. 10, 2005, 119 Stat. 1911, provided that: “This subtitle [subtitle B (§§ 7201–7204) of title VII of Pub. L. 109–59, enacting section
350e of this title, amending sections
331,
342, and
373 of this title and section
5701 of Title
49, Transportation, omitting sections
5702 to
5714 of Title
49, and enacting provisions set out as a note under section
331 of this title] may be cited as the ‘Sanitary Food Transportation Act of 2005’.”

Pub. L. 109–43, § 1,Aug. 1, 2005, 119 Stat. 439, provided that: “This Act [amending sections
352 and
379j of this title, enacting provisions set out as a note under section
352 of this title, and amending provisions set out as notes under sections
352 and
379i of this title] may be cited as the ‘Medical Device User Fee Stabilization Act of 2005’.”

Short Title of 2004 Amendments

Pub. L. 108–282, title I, § 101,Aug. 2, 2004, 118 Stat. 891, provided that: “This title [enacting sections
360ccc to
360ccc–2 of this title, amending sections
321,
331,
352,
353,
354, and
360b of this title, enacting provisions set out as notes under sections
360ccc and
393 of this title, and amending provisions set out as a note under section
360b of this title] may be cited as the ‘Minor Use and Minor Species Animal Health Act of 2004’.”

Pub. L. 108–282, title II, § 201,Aug. 2, 2004, 118 Stat. 905, provided that: “This title [enacting section
374a of this title and section
242r of Title
42, The Public Health and Welfare, amending sections
321,
343, and
343–1 of this title, and enacting provisions set out as notes under sections
321 and
343 of this title and sections
243 and
300d–2 of Title
42] may be cited as the ‘Food Allergen Labeling and Consumer Protection Act of 2004’.”

Pub. L. 108–155, § 1,Dec. 3, 2003, 117 Stat. 1936, provided that: “This Act [enacting section
355c of this title, amending sections
355,
355a, and
355b of this title and sections
262 and
284m of Title
42, The Public Health and Welfare, enacting provisions set out as a note under section
355c of this title, and amending provisions set out as notes under section
355a of this title and section
284m of Title
42] may be cited as the ‘Pediatric Research Equity Act of 2003’.”

Pub. L. 108–130, § 1,Nov. 18, 2003, 117 Stat. 1361, provided that: “This Act [enacting sections
379j–11 and
379j–12 of this title and provisions set out as notes under section
379j–11 of this title] may be cited as the ‘Animal Drug User Fee Act of 2003’.”

Short Title of 2002 Amendments

Pub. L. 107–281, § 1,Nov. 6, 2002, 116 Stat. 1992, provided that: “This Act [amending sections
360cc and
360ee of this title and enacting provisions set out as a note under section
360ee of this title] may be cited as the ‘Rare Diseases Orphan Product Development Act of 2002’.”

Pub. L. 107–188, title V, § 501,June 12, 2002, 116 Stat. 687, provided that: “This subtitle [subtitle A (§§ 501–509) of title V of Pub. L. 107–188, amending sections
356b,
379g, and
379h of this title and enacting provisions set out as notes under sections
356b and
379g of this title] may be cited as the ‘Prescription Drug User Fee Amendments of 2002’.”

Pub. L. 107–109, § 1,Jan. 4, 2002, 115 Stat. 1408, provided that: “This Act [enacting sections
355b and
393a of this title and section
284m of Title
42, The Public Health and Welfare, amending sections
321,
355,
355a, and
379h of this title and sections
282,
284k,
284l,
285a–2, and
290b of Title
42, and enacting provisions set out as notes under sections
355 and
355a of this title and sections
284m and
289 of Title
42] may be cited as the ‘Best Pharmaceuticals for Children Act’.”

Short Title of 2000 Amendment

Pub. L. 106–387, § 1(a) [title VII, § 745(a)], Oct. 28, 2000, 114 Stat. 1549, 1549A–35, provided that: “This section [enacting section
384 of this title, amending sections
331,
333, and
381 of this title, and enacting provisions set out as a note under section
384 of this title] may be cited as the ‘Medicine Equity and Drug Safety Act of 2000’.”

Pub. L. 106–387, § 1(a) [title VII, § 746(a)], Oct. 28, 2000, 114 Stat. 1549, 1549A–40, provided that: “This section [amending section
381 of this title and enacting provisions set out as a note under section
381 of this title] may be cited as the ‘Prescription Drug Import Fairness Act of 2000’.”

Pub. L. 104–250, § 1(a),Oct. 9, 1996, 110 Stat. 3151, provided that: “This Act [enacting section
354 of this title, amending sections
331,
353, and
360b of this title, and enacting provisions set out as notes under section
360b of this title] may be cited as the ‘Animal Drug Availability Act of 1996’.”

[Another “Food Quality Protection Act of 1996”, was enacted by Pub. L. 104–170, § 1,
110 Stat. 1489, which is set out as a note under section
136 of Title
7, Agriculture.]

Pub. L. 104–134, title II, § 2101(a),Apr. 26, 1996, 110 Stat. 1321–313, provided that: “This chapter [chapter 1A (§§ 2101–2105) of title II of Pub. L. 104–134, enacting section
382 of this title and amending sections
331 and
381 of this title and section
262 of Title
42, The Public Health and Welfare] may be cited as the ‘FDA Export Reform and Enhancement Act of 1996’.”

Short Title of 1994 Amendments

Pub. L. 103–417, § 1(a),Oct. 25, 1994, 108 Stat. 4325, provided that: “This Act [enacting sections
343–2 and
350b of this title and section
287c–11 of Title
42, The Public Health and Welfare, amending sections
321,
331,
342,
343, and
350 of this title and section
281 of Title
42, and enacting provisions set out as notes under sections
321 and
343 of this title] may be cited as the ‘Dietary Supplement Health and Education Act of 1994’.”

Pub. L. 103–396, § 1,Oct. 22, 1994, 108 Stat. 4153, provided that: “This Act [amending sections
331,
343–1,
360b, and
371 of this title and enacting provisions set out as notes under section
360b of this title] may be cited as the ‘Animal Medicinal Drug Use Clarification Act of 1994’.”

Pub. L. 102–571, title I, § 101(a),Oct. 29, 1992, 106 Stat. 4491, provided that: “This title [enacting sections
379g and
379h of this title, transferring sections
372a,
376, and
379c of this title to sections
376,
379e and
379f, respectively, of this title, amending sections
321,
331,
342,
343,
346a,
351,
352,
360j,
361,
362,
453,
601, and
1033 of this title, enacting provisions set out as notes under section
379g of this title, and amending provisions set out as notes under sections
343 and
343–1 of this title] may be cited as the ‘Prescription Drug User Fee Act of 1992’.”

Pub. L. 102–571, title II, § 201,Oct. 29, 1992, 106 Stat. 4500, provided that: “This title [enacting provisions set out as notes under sections
343 and
393 of this title and amending provisions set out as notes under sections
343 and
343–1 of this title] may be cited as the ‘Dietary Supplement Act of 1992’.”

Pub. L. 102–353, § 1(a),Aug. 26, 1992, 106 Stat. 941, provided that: “This Act [amending sections
333,
353, and
381 of this title and enacting provisions set out as a note under section
353 of this title] may be cited as the ‘Prescription Drug Amendments of 1992’.”

Pub. L. 102–282, § 1(a),May 13, 1992, 106 Stat. 149, provided that: “This Act [enacting sections
335a to
335c of this title, amending sections
321,
336,
337, and
355 of this title, and enacting provisions set out as notes under section
335a of this title] may be cited as the ‘Generic Drug Enforcement Act of 1992’.”

Pub. L. 101–629, § 1(a),Nov. 28, 1990, 104 Stat. 4511, provided that: “This Act [enacting sections
360l and
383 of this title, amending sections
321,
333,
351,
353, and
360c to
360j of this title and sections
263b to
263n of Title
42, The Public Health and Welfare, redesignating sections
263b to
263n of Title
42 as sections
360gg to
360ss of this title, repealing section
263b of Title
42, and enacting provisions set out as notes under sections
333,
360c,
360i,
360j,
360hh and
383 of this title] may be cited as the ‘Safe Medical Devices Act of 1990’.”

Pub. L. 101–535, § 1(a),Nov. 8, 1990, 104 Stat. 2353, provided that: “This Act [enacting section
343–1 of this title, amending sections
321,
337,
343,
345, and
371 of this title, and enacting provisions set out as notes under sections
343 and
343–1 of this title] may be cited as the ‘Nutrition Labeling and Education Act of 1990’.”

Short Title of 1988 Amendments

Pub. L. 100–670, § 1(a),Nov. 16, 1988, 102 Stat. 3971, provided that: “This Act [amending sections
321,
353, and
360b of this title, section
2201 of Title
28, Judiciary and Judicial Procedure, and sections
156 and
271 of Title
35, Patents, and enacting provisions set out as notes under section
360b of this title] may be cited as the ‘Generic Animal Drug and Patent Term Restoration Act’.”

Pub. L. 100–607, title V, § 501,Nov. 4, 1988, 102 Stat. 3120, provided that: “This title [enacting section
393 of this title, amending sections
5315 and
5316 of Title
5, Government Organization and Employees, and enacting provisions set out as notes under section
393 of this title] may be cited as the ‘Food and Drug Administration Act of 1988’.”

Pub. L. 100–293, § 1(a),Apr. 22, 1988, 102 Stat. 95, provided that: “This Act [amending sections
331,
333,
353, and
381 of this title and enacting provisions set out as notes under section
353 of this title] may be cited as the ‘Prescription Drug Marketing Act of 1987’.”

Pub. L. 100–290, § 1,Apr. 18, 1988, 102 Stat. 90, provided that: “This Act [amending sections
360bb and
360ee of this title, enacting provisions set out as a note under section
360aa of this title, and amending provisions set out as a note under section
236 of Title
42, The Public Health and Welfare] may be cited as the ‘Orphan Drug Amendments of 1988’.”

Short Title of 1986 Amendment

Pub. L. 99–660, title I, § 101(a),Nov. 14, 1986, 100 Stat. 3743, provided that: “This title [enacting section
382 of this title, amending sections
241 and
262 of Title
42, The Public Health and Welfare, and enacting provisions set out as notes under section
333 of this title and section
262 of Title
42] may be cited as the ‘Drug Export Amendments Act of 1986’.”

Short Title of 1985 Amendment

Pub. L. 99–91, § 1,Aug. 15, 1985, 99 Stat. 387, provided that: “This Act [amending sections
360aa to
360cc, and
360ee of this title, and sections
295g–1 and
6022 of Title
42, The Public Health and Welfare, and enacting provisions set out as notes under section
360aa of this title and section
236 of Title
42] may be cited as the ‘Orphan Drug Amendments of 1985’.”

Short Title of 1984 Amendment

Pub. L. 98–417, § 1,Sept. 24, 1984, 98 Stat. 1585, provided: “That this Act [enacting section
156 of Title
35, Patents, amending sections
355 and
360cc of this title, sections
68b,
68c, and
70b of Title
15, Commerce and Trade, section
2201 of Title
28, Judiciary and Judicial Procedure, and sections
271 and
282 of Title
35, and enacting provisions set out as notes under section
355 of this title and section
68b of Title
15] may be cited as the ‘Drug Price Competition and Patent Term Restoration Act of 1984’.”

Short Title of 1983 Amendments

Pub. L. 98–22, § 1,Apr. 22, 1983, 97 Stat. 173, provided: “That this Act [amending provisions set out as a note under section
348 of this title] may be cited as the ‘Saccharin Study and Labeling Act Amendment of 1983’.”

Pub. L. 97–42, § 1,Aug. 14, 1981, 95 Stat. 946, provided: “That this Act [amending provisions set out as a note under section
348 of this title] may be cited as the ‘Saccharin Study and Labeling Act Amendment of 1981’.”

Short Title of 1980 Amendment

Pub. L. 96–359, § 1,Sept. 26, 1980, 94 Stat. 1190, provided: “That this Act [enacting section
350a of this title, amending sections
321,
331,
374,
830,
841 to
843, and
873 of this title, and enacting a provision set out as a note under section
350a of this title] may be cited as the ‘Infant Formula Act of 1980’.”

Short Title of 1977 Amendment

Pub. L. 95–203, § 1,Nov. 23, 1977, 91 Stat. 1451, provided that: “This Act [enacting section
343a of this title, amending sections
321 and
343 of this title, enacting provisions set out as notes under sections
343 and
348 of this title, and amending provisions set out as notes under sections
218 and
289l–1 of Title
42, The Public Health and Welfare] may be cited as the ‘Saccharin Study and Labeling Act’.”

Pub. L. 92–387, § 1,Aug. 16, 1972, 86 Stat. 559, provided that: “This Act [amending sections
331,
335, and
360 of this title and enacting provisions set out as notes under section
360 of this title] may be cited as the ‘Drug Listing Act of 1972’.”

Short Title of 1968 Amendments

Pub. L. 90–602, § 1,Oct. 18, 1968, 82 Stat. 1173, provided that: “This Act [enacting provisions now comprising part C (§§ 360hh–360ss) of subchapter III of this chapter and provisions set out as notes under section
360hh of this title] may be cited as the ‘Radiation Control for Health and Safety Act of 1968’.”

Pub. L. 90–399, § 1,July 13, 1968, 82 Stat. 342, provided: “That this Act [enacting section
360b of this title, amending sections
321,
331,
342,
351,
352,
357,
381, and
392 of this title, and enacting provisions set out as a note under section
360b of this title] may be cited as the ‘Animal Drug Amendments of 1968’.”

Short Title of 1965 Amendment

Pub. L. 89–74, § 1,July 15, 1965, 79 Stat. 226, provided: “That this Act [amending sections
321,
331,
333,
334,
360, and
372 of this title and section
1114 of Title
18, Crimes and Criminal Procedure, and enacting provisions set out as notes under sections
321 and
352 of this title] may be cited as the ‘Drug Abuse Control Amendments of 1965’.”

Pub. L. 85–929, § 1,Sept. 6, 1958, 72 Stat. 1784, provided: “That this Act [amending sections
321,
331,
342,
346,
348 of this title and section
210 of Title
42, The Public Health and Welfare, and enacting provisions set out as notes under sections
321,
342, and
451 of this title] may be cited as the ‘Food Additives Amendment of 1958’.”

Severability

Pub. L. 113–54, title I, § 106(b),Nov. 27, 2013, 127 Stat. 598, provided that: “If any provision of this Act [see Short Title of 2013 Amendment note above] (including the amendments made by this Act) is declared unconstitutional, or the applicability of this Act (including the amendments made by this Act) to any person or circumstance is held invalid, the constitutionality of the remainder of this Act (including the amendments made by this Act) and the applicability thereof to other persons and circumstances shall not be affected.”

Pub. L. 110–85, title XI, § 1105,Sept. 27, 2007, 121 Stat. 975, provided that: “If any provision of this Act [see Short Title of 2007 Amendment note above], an amendment made [by] this Act, or the application of such provision or amendment to any person or circumstance is held to be unconstitutional, the remainder of this Act, the amendments made by this Act, and the application of the provisions of such to any person or circumstances shall not be affected thereby.”

Hazardous Substances

Federal Hazardous Substances Act as not modifying this chapter, see Pub. L. 86–613, § 18,July 12, 1960, 74 Stat. 380, set out as an Effect Upon Federal and State Laws note under section
1261 of Title
15, Commerce and Trade.